share

Cyclopropa[3,4]Cyclopenta[1,2-B]Quinoxaline (9Ci) CAS NO 114535-15-8


Unit Price:

CAS No.:114535-15-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Cyclopropa[3,4]Cyclopenta[1,2-B]Quinoxaline (9Ci) is a high-purity, fused heterocyclic organic compound of significant interest in advanced chemical synthesis. This specialized chemical serves as a critical building block for the development of novel materials and active pharmaceutical ingredients (APIs). It is primarily utilized by research institutions and industrial R&D departments engaged in cutting-edge organic chemistry and medicinal chemistry programs.

Application

  • Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug candidates, particularly those targeting neurological or oncological pathways.
  • Organic Light-Emitting Diode (OLED) Research: Investigated as a potential electron-transport or emissive layer material due to its fused-ring, electron-deficient quinoxaline core.
  • Agrochemical Development: Used in research for creating novel herbicides or pesticides with specific modes of action.
  • Material Science: Acts as a monomer or building block for constructing advanced polymers with tailored electronic or optical properties.
  • Academic & Industrial R&D: Employed in methodological studies and discovery chemistry for novel heterocyclic compounds.
  • Ligand Synthesis: Potential use in constructing chelating ligands for catalysis or metal-organic frameworks (MOFs).

Basic Information

Product Name Cyclopropa[3,4]Cyclopenta[1,2-B]Quinoxaline (9Ci)
CAS No. 114535-15-8
Molecular Formula C12H6N2
Molecular Weight 178.19 g/mol
Synonyms Cyclopropa[3,4]cyclopenta[1,2-b]quinoxaline; 1,2-Dihydro-1,2-ethano-1,2-ethenocyclopropa[3,4]cyclopenta[1,2-b]quinoxaline; 1,2-Ethano-1,2-ethenocyclopropa[3,4]cyclopenta[1,2-b]quinoxaline; 9CI Index Name; Cyclopropa[3,4]cyclopenta[1,2-b]quinoxaline (9CI)
EINECS Contact for details

Quality Control

Our Cyclopropa[3,4]Cyclopenta[1,2-B]Quinoxaline (9Ci) is manufactured under strict quality protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot undergoes comprehensive analytical characterization, including HPLC for purity and NMR for structural confirmation. A detailed Certificate of Analysis (COA) documenting identity, purity, and impurity profile is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain product integrity.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 95.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.